What needs improving in REACH?
Environmental groups would like to see the following in REACH:
-
an obligation to phase out chemicals that accumulate in humans, wildlife or the
environment, and those that interfere with our hormone systems or cause cancer.
Restricted uses of such chemicals should only be permitted temporarily if safer
alternatives are not available and there is an over-riding societal need for the
specific use;
-
a full right to know, so that consumers and businesses can judge the risks from
chemicals, and including information about all dangerous chemicals present in
products; and
-
a requirement that products imported into the EU should conform to the same
safety standards as those made in the EU.
- Provide sufficient safety data to identify dangerous chemicals and safer alternatives.
These points are not fully incorporated in the current draft of REACH. For
example, a loophole in authorisation means that some of the worst chemicals
could continue to be used indefinitely even if substitutes are available.
^top
When will REACH become law?
The European Commission published its proposed legislation in October 2003. This
is now being discussed by the European Parliament and Council. But the massive
lobbying power of the chemical industry has already delayed Parliament's work by
a year. The final agreement is expected in the beginning of 2007. The law then becomes effective immediately, although chemicals will
be phased into the REACH scheme.
A more detailed timetable can be
seen here >
^top
Which chemicals should we be worried about?
The most hazardous chemicals are known as chemicals of "very high concern".
These are chemicals that:
-
do not break down quickly in the environment (very persistent chemicals) and can
build up inside our bodies (very bio-accumulative chemicals); or have a
combination of persistence, bio-accumulation and toxicity;
-
are able to disturb our hormone systems (endocrine disrupters);
-
can cause cancer (carcinogenic);
-
can alter genes (mutagenic); or
-
are toxic to the reproductive system;
-
or are of "equivalent" concern.
There is increasing evidence that some synthetic chemicals are harming health.
For example, chemicals are suspected of contributing to breast and testicular
cancers, leukaemia, some allergies, reproductive problems and birth defects,
early puberty in girls, and falling sperm counts. Chemicals also cause many
cases of occupational diseases. For more information see: www.foe.co.uk/resource/factsheets/chemicals_and_your_health.html
www.greenpeace.org.uk/Products/Toxics/humanbody.cfm
^top
Are there any examples of problem chemicals in everyday
products?
Yes, many. For example:
Alkyltin compounds / organotin compounds: used as anti-bacterial agents and
catalysts in the production of some plastics, eg, in some PVC and packaging.
They are persistent, bio-accumulative and believed to interfere with hormone
systems. Alkyltins can also attack the immune system and neurons in the brain.
Bisphenol A: used in the manufacture of linings for some food cans and lids, and
is an ingredient in polycarbonate plastic bottles. It is a hormone disrupter and
is suspected of affecting female and male reproductive organs.
Brominated flame retardants (BFRs) : used in fabrics in furniture and plastics (e.g.
in personal computers) to counteract the spread of fires. Most BFRs are
persistent and bio-accumulative, and several have been identified as hormone
disrupters. Exposure has been shown to interfere with brain development in
animals.
Phthalates: used in many PVC products (eg vinyl floor tiles, toys), glues and
inks and as solvents in cosmetics and toiletries. A number of phthalates are
hormone disrupters. Some cause liver, kidney and testicular damage.
Alkylphenols and derivatives: used as industrial detergents, and used in some
paints and plastics. They are hormone disrupters and they can damage the immune
system.
Artificial musks: fragrances added to many products like perfumes, cosmetics and
laundry detergents. These are persistent and bio-accumulative and some are
hormone disrupters. May cause liver damage and interfere with brain function.
Triclosan: an anti-bacterial chemical (sometimes marketed under the name "Microban
") which is added to a wide range of products, including washing-up liquids,
liquid soaps, mouthwashes, dishcloths and chopping boards. It is now being
detected as a contaminant in human breast milk and fish which demonstrates its
poor breakdown in the environment and its ability to contaminate our bodies.
For more information, see www.foe.co.uk/resource/briefings/risky_chemicals_in_the_home.pdf
(
PDF - 89K) [English]
www.greenpeace.org.uk/Products/Toxics/chemicalhouse.cfm
[English]
www.chemical-cocktail.org/index_en.asp
[English]
www.chemical-cocktail.org/index_fr.asp
[French]
^top
How will registration work under REACH?
Manufacturers and importers will be required to document the safety of their
substances. Therefore they will have to know about the chemical's properties,
get information on uses from their clients, judge the risks the different
chemical uses are posing to environment and human health and take/recommend
safety measures. How much documentation is needed in the first instance will
depend on the production volume of the chemical. Companies will be required to
register all substances produced or imported in volumes of one tonne or more per
year per manufacturer or importer (estimated to be around 30,000 substances).
The shortest deadlines for registration will apply to very high volume
substances (above 1000 tonnes), and carcinogenic, mutagenic or reproductive
toxics above one tonne. These will have to be registered within three years of
REACH becoming law. Chemicals with production volumes in the range of 100 - 1,000
tonnes will have to be registered within six years; and low production volume
chemicals (1 - 100 tonnes) will have 11 years for registration.
^top
What is evaluation?
The adequacy of or need for further information in the registration dossiers can
be evaluated by the national authorities if the substance presents a risk to
health or the environment. Any industry proposal for testing on animals will
have to be checked and agreed by the authorities. Data (including existing data)
from animal tests will have to be shared and this will avoid much new testing.
^top
Which chemicals will require authorisation?
Only substances of very high concern (see Question 6) will be subject to
authorisation. An authorisation will grant permission for the substance to be
used in specified uses only. As the draft stands, authorisation can be granted
if the producer or importer can show that risks from the use in question can be
"adequately controlled", or that the socio-economic benefits of the use of the
substance outweigh the risks. In the latter case, the possibility of
substitution with a less hazardous chemical should be considered.
Our view is that "adequate control" of very persistent and bio-accumulative
chemicals is a flawed concept and that such chemicals should be phased out
because of these intrinsic physical properties, without having to prove that
they are harmful.
^top
Market and use restrictions
Next to the authorisation process, which will be completely controlled by a new
international Agency, Member States can propose market and use restrictions for
any chemical which they believe poses an unacceptable risk. This unfortunately
continues the existing EU mechanism for controlling chemical risks and continues
to put the burden of proof on the authorities. In the past this approach has not
delivered sufficient protection and has only provided for regulatory action
mostly after the damaged has happened. REACH might improve on this situation
somewhat due to the collection of information at the registration process, but
the restriction process overlaps with the authorisation procedure and does not
provide for a clear paradigm shift to a precautionary approach in the way we
deal with chemicals.
^top
What
are the health and environmental benefits of REACH?
It is impossible to assign an exact value to the benefits of REACH.
But they are expected to be highly significant and certainly outweigh
the costs to industry. According to the European Commission, REACH
might prevent over 4,000 deaths per year [1]. A modest 0.1% reduction
in diseases related to chemicals would be worth 50 billion
over the next 30 years. In addition, there will also be considerable
environmental benefits, including to wildlife.
^top
What
will be the costs of REACH?
The European Commission has estimated that (as the draft stands)
the registration and testing costs would be 2.3bn over 11
years (this includes fees to set up the new Chemicals Agency) [2].
This represents less than 0.05 per cent of chemical industry turnover,
and only 2.7 per cent of current environmental spending and 2.4
per cent of the Research & Development programme of the industry.
Alternatively, 2.3 billion corresponds to around 50 cents
per EU citizen per year - or less than the cost of a chocolate bar
[3].
^top
How will REACH affect business?
Despite alarmist claims by some sections of industry and the chemical lobby,
over 40 impact studies (by whom?) have pointed to comparatively small costs for
industry but great long-term benefits for businesses as well as consumers.
The former director general of the Confederation of British Industry and now
vice chairman of Merrill Lynch, Adair Turner, has made the case for the use of
regulation and taxes to promote environmental aims and has demolished the
conventional arguments that they harm competitiveness and jobs [4].
The benefits to business of REACH include:
-
harmonised standards for old and new chemicals.
-
a more predictable regulatory system that will aid future long-term planning by
industry.
-
increased trust among consumers leading to new markets for safer and more
environmentally friendly products allowing an easier introduction of new
products and
-
positive, forward-thinking development and innovation
-
reduced the risk of future liability lawsuits, which can result in enormous
costs (as has happened with asbestos).
Improved transparency and communication through the supply chain leading to
increased power and confidence for downstream users and SMEs [5].
^top
How many animals will be used for testing the safety of
chemicals?
REACH will require some animal testing in some cases. However REACH is taking
many steps to reduce animal testing in the long term through:
-
requiring the sharing of animal test data (including existing but previously
private data);
-
promoting development of non-animal tests and increasing the emphasis on the use
of computer-modelling techniques;
-
and by promoting a precautionary approach to the authorisation of chemicals of
very high concern.
Environmental groups along with animal right groups strongly support mandatory
data sharing to avoid unnecessary animal tests. In addition, we believe the very
persistent and very bio-accumulative chemicals should be phased out without
having to prove their toxicity.
It has been claimed that 13 million vertebrate animals could be used for tests.
This claim is based on an outdated report [6] using the assumption that all 30,000
chemicals will need testing and that there is no available information from past
testing programmes. The true figure will be far less.
^top
Are there chemicals that will not be included in REACH?
Pesticides, medicines, pharmaceuticals and cosmetics, and natural products will
generally be outside the scope of REACH where they are covered by other
legislation. However, there is no definitive list of chemicals that REACH will
or will not cover.
^top
References
[1] European Commission, 2003, Extended Impact Assessment, 29 Oct 2003 , p. 11
[2] European Commission, 2003, Q and A on the new chemicals policy REACH
[3] International Chemical Secretariat, Feb 2004, Fact sheet, www.chemsec.org
[4] The Observer, 2003, When regulation is good, 27 July 2003
http://observer.guardian.co.uk/business/story/0,6903,1006462,00.html
[5] ' EEB and WWF discussion paper,
January 2003, A new chemicals policy in Europe - new opportunities
for industry.
www.eeb.org/activities/chemicals/Newchemicalspolicy-industry-29-01-03.pdf
(
PDF)
[6] UK Institute for Environment
and Health, 2001, Testing requirements for proposals under the EC
White Paper 'Strategy for a future chemicals policy' . Institute
for Environment and Health, Leicester, UK .
www.le.ac.uk/ieh/pdf/w6.pdf (
PDF)